Related Experiment Video
Updated: Jul 15, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Disorders of bone and mineral metabolism in CKD: CKD-MBD as a new entity]
1Shuwa General Hospital, Division of Nephrology, Japan.
Insights
Chronic kidney disease (CKD) patients face reduced life expectancy due to vascular calcification. A new entity, CKD-bone mineral disorder (CKD-MBD), and its classifications (TMV, LBC) are introduced to better describe these complex pathologies.
Area of Science:
- Nephrology
- Bone and Mineral Metabolism
Background:
- Vascular calcification in chronic kidney disease (CKD) significantly reduces patient life expectancy.
- The term "renal osteodystrophy" is insufficient to encompass the full scope of bone and mineral disorders in CKD.
Purpose of the Study:
- Introduce the new disease entity "CKD-bone mineral disorder (CKD-MBD)" to accurately reflect the pathophysiology.
- Present new pathological classifications for CKD-MBD: the TMV (turnover, mineralization, volume) and LBC (laboratory abnormalities, bone abnormalities, extra osseous calcification) classifications.
Main Methods:
- The Global Bone and Mineral Initiative (GBMI), a workgroup of KDIGO (Kidney Disease Improving Global Outcome), developed the new terminology and classifications.
- Review of existing literature and clinical data to define CKD-MBD and establish classification criteria.
Main Results:
- The term CKD-MBD is proposed as a more comprehensive descriptor for bone and mineral disorders in CKD patients.
- Two novel classification systems, TMV and LBC, have been developed for pathological assessment of CKD-MBD.
Conclusions:
- CKD-MBD is a critical consideration in managing chronic kidney disease.
- The TMV and LBC classifications provide a standardized framework for understanding and diagnosing bone and mineral disorders in CKD.
Abstract:
Since vascular calcification due to mineral disorder has been revealed a chief cause of decreasing life expectancy of chronic kidney disease (CKD) patients in recent years, the term "renal osteodystrophy" can no longer express the pathophysiology of entire bone and mineral disorder in CKD. This is the reason why new disease entity "CKD-bone mineral disorden (MBD)" was introduced by the GBMI (Global Bone and Mineral Initiative) (one of the workgroups of KDIGO [Kidney Disease Improving Global Outcome]). GBMI has also produced new pathological classification of renal osteodystrophy (ROD) as TMV (turnover, mineralization, volume) classification and LBC (laboratory abnormalities, bone abnormalities, extra osseous calcification) classification for CKD-MBD.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease II: Clinical Manifestations
What is the Skeletal System?
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Bone Remodeling
